NASDAQ
Adverum Biotechnologies, Inc. (ADVM) has a current ratio of 5.73x as of Monday, May 25, 2026. This represents a 50.93% decrease compared to its 12-month average of 11.69x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.